First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia Our study demonstrated that ...

Implementing a genomic oncology program in an integrated health care network with large scale genomic Next Generation Sequencing (NGS) testing of advanced cancers in a community setting. Review of ...

John Kinghorn ’s RHG has resolved to make its first dividend payment after the emphatic rejection of the company’s buyback proposal by shareholders yesterday. Management of the former non-bank lender, ...

Pepper, which typically provides low-doc loans, yesterday unveiled an offer of 46c a share for RHG, which it claimed was "superior" to a bid by rival non-bank Resimac and dealmaker Trevor Loewensohn.

Listed mortgage company RHG, formally RAMS Mortgage Corp, has engaged with suitor Resimac and opened the door to a period of due diligence on the $128 million proposal. RHG has executed ...